We are live on
!
Find out more
EAM
Erste Asset Management Portfolio holdings
AUM
$12.9B
1-Year Est. Return
52.69%
This Fund
S&P 500
This Quarter
Est. Return
-16.19%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
–
AUM
$1.49B
AUM Growth
–
Cap. Flow
+$1.64B
Cap. Flow
% of AUM
110.29%
Top 10 Holdings %
Top 10 Hldgs %
25.03%
Holding
443
New
443
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sarepta Therapeutics
SRPT
|
+$63.6M |
| 2 |
Microsoft
MSFT
|
+$62.3M |
| 3 |
CELG
Celgene Corp
CELG
|
+$52.1M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$37.9M |
| 5 |
Agios Pharmaceuticals
AGIO
|
+$34.5M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.02% |
| 2 | Technology | 21.31% |
| 3 | Consumer Discretionary | 14.52% |
| 4 | Financials | 8.82% |
| 5 | Communication Services | 6.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Repligen
RGEN
$9.86B
| $754K | 0.05% |
+14,920
| New | +$875K |
|
252
Insmed
INSM
$26.2B
| $751K | 0.05% |
+57,700
| New | +$921K |
|
253
NetEase
NTES
$76.5B
| $739K | 0.05% |
+15,000
| New | +$677K |
|
254
Halliburton
HAL
$29.7B
| $738K | 0.05% |
+28,000
| New | +$945K |
|
255
Acadia Pharmaceuticals
ACAD
$4.61B
| $714K | 0.05% |
+46,200
| New | +$897K |
|
|
BLDP
256
Ballard Power Systems
BLDP
$639M
| $707K | 0.05% |
+275,000
| New | +$865K |
|
257
Credicorp
BAP
$29.6B
| $695K | 0.05% |
+3,164
| New | +$699K |
|
258
Becton Dickinson
BDX
$50.6B
| $667K | 0.04% |
+3,075
| New | +$714K |
|
259
TAL Education Group
TAL
$6.52B
| $657K | 0.04% |
+25,000
| New | +$663K |
|
|
GBT
260
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $638K | 0.04% |
+16,000
| New | +$600K |
|
261
SLB Ltd
SLB
$80.4B
| $630K | 0.04% |
+17,350
| New | +$856K |
|
262
American Financial Group
AFG
$11.9B
| $624K | 0.04% |
+7,000
| New | +$702K |
|
263
Fidelity National Financial
FNF
$11.7B
| $624K | 0.04% |
+20,800
| New | +$671K |
|
264
Mercado Libre
MELI
$92.7B
| $623K | 0.04% |
+2,155
| New | +$698K |
|
265
Newmont
NEM
$131B
| $618K | 0.04% |
+17,786
| New | +$577K |
|
|
Y
266
DELISTED
Alleghany Corp
Y
| $617K | 0.04% |
+1,000
| New | +$616K |
|
267
Canadian National Railway
CNI
$73.7B
| $605K | 0.04% |
+8,260
| New | +$685K |
|
268
Phillips 66
PSX
$106B
| $601K | 0.04% |
+7,000
| New | +$684K |
|
269
Pacira BioSciences
PCRX
$960M
| $599K | 0.04% |
+14,400
| New | +$672K |
|
|
MYOK
270
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $598K | 0.04% |
+11,700
| New | +$644K |
|
271
Voya Financial
VOYA
$9.28B
| $593K | 0.04% |
+15,000
| New | +$666K |
|
272
Veeco
VECO
$2.5B
| $592K | 0.04% |
+80,000
| New | +$684K |
|
273
Marathon Petroleum
MPC
$115B
| $591K | 0.04% |
+10,000
| New | +$682K |
|
274
KeyCorp
KEY
$23.2B
| $585K | 0.04% |
+40,000
| New | +$704K |
|
|
FOLD
275
DELISTED
Amicus Therapeutics
FOLD
| $581K | 0.04% |
+62,600
| New | +$688K |
|
Similar funds
FFA
GKIM
WI
CRM
PCM
BCI
VLKIM
BAMF
Erste Asset Management's Q4 2018 Portfolio in Review
Q4 2018 is the first quarter with a 13F filing on record for Erste Asset Management, which disclosed 443 positions worth $1.49B. Its ten largest holdings account for 25% of the portfolio.
Its largest position is Sarepta Therapeutics: 508,810 shares worth $54.8M.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, followed by Technology and Consumer Discretionary.
- Erste Asset Management's largest Q4 2018 buy was Sarepta Therapeutics: 508,810 shares worth $54.8M.
- Erste Asset Management's ten largest holdings make up 25% of its $1.49B portfolio in Q4 2018.
- Erste Asset Management disclosed 443 positions in Q4 2018, its first 13F filing on record.
Based on Erste Asset Management's 13F filing for Q4 2018, filed 26 Nov 2024.